Andrew M - Search Results

1

Guidelines for antithrombotic therapy in pediatric patients.

Andrew M, Michelson AD, Bovill E, Leaker M, Massicotte MP. Andrew M, et al. J Pediatr. 1998 Apr;132(4):575-88. doi: 10.1016/s0022-3476(98)70343-9. J Pediatr. 1998. PMID: 9580753 Review.

2

Thrombolytic therapy in pediatric patients: a comprehensive review of the literature.

Leaker M, Massicotte MP, Brooker LA, Andrew M. Leaker M, et al. Among authors: andrew m. Thromb Haemost. 1996 Aug;76(2):132-4. Thromb Haemost. 1996. PMID: 8865517 Review. No abstract available.

3

Heparin therapy in pediatric patients.

Sutor AH, Massicotte P, Leaker M, Andrew M. Sutor AH, et al. Among authors: andrew m. Semin Thromb Hemost. 1997;23(3):303-19. doi: 10.1055/s-2007-996103. Semin Thromb Hemost. 1997. PMID: 9255911 Review.

4

Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications.

Massicotte MP, Dix D, Monagle P, Adams M, Andrew M. Massicotte MP, et al. Among authors: andrew m. J Pediatr. 1998 Dec;133(6):770-6. doi: 10.1016/s0022-3476(98)70149-0. J Pediatr. 1998. PMID: 9842042

5

Spontaneous arterial thrombosis in children.

Streif W, Monagle P, South M, Leaker M, Andrew M. Streif W, et al. Among authors: andrew m. J Pediatr. 1999 Jan;134(1):110-2. doi: 10.1016/s0022-3476(99)70382-3. J Pediatr. 1999. PMID: 9880460

6

The use of low molecular weight heparin in pediatric patients: a prospective cohort study.

Dix D, Andrew M, Marzinotto V, Charpentier K, Bridge S, Monagle P, deVeber G, Leaker M, Chan AK, Massicotte MP. Dix D, et al. Among authors: andrew m. J Pediatr. 2000 Apr;136(4):439-45. doi: 10.1016/s0022-3476(00)90005-2. J Pediatr. 2000. PMID: 10753240 Clinical Trial.

7

The use of alteplase to restore patency of central venous lines in pediatric patients: a cohort study.

Choi M, Massicotte MP, Marzinotto V, Chan AK, Holmes JL, Andrew M. Choi M, et al. Among authors: andrew m. J Pediatr. 2001 Jul;139(1):152-6. doi: 10.1067/mpd.2001.115019. J Pediatr. 2001. PMID: 11445811

8

Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children.

Gupta AA, Leaker M, Andrew M, Massicotte P, Liu L, Benson LN, McCrindle BW. Gupta AA, et al. Among authors: andrew m. J Pediatr. 2001 Nov;139(5):682-8. doi: 10.1067/mpd.2001.118428. J Pediatr. 2001. PMID: 11713447

9

Fibrin clot lysis by tissue plasminogen activator (tPA) is impaired in plasma from pediatric patients undergoing orthotopic liver transplantation.

Leaker MT, Brooker LA, Mitchell LG, Weitz JI, Superina R, Andrew ME. Leaker MT, et al. Among authors: andrew me. Transplantation. 1995 Jul 27;60(2):144-7. Transplantation. 1995. PMID: 7624956

10

The prevention and treatment of thromboembolic disease in children: a need for Thrombophilia Programs.

Andrew M, Michelson AD, Bovill T, Leaker M, Massicotte P, Marzinotto V, Brooker LA. Andrew M, et al. J Pediatr Hematol Oncol. 1997 Jan-Feb;19(1):7-22. doi: 10.1097/00043426-199701000-00002. J Pediatr Hematol Oncol. 1997. PMID: 9065714 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

940 results

Search Page

Filters